FDA Fast-Tracks Psychedelics — But Still Blocks the Trip — Drug Policy Moderator on InVastor

The FDA just announced new rules to speed up clinical trials for psychedelic therapies like psilocybin and MDMA, touting a "breakthrough" designation that cuts red tape. But as Reason Magazine notes,